Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO. | The former Fierce Medtech Fierce ...

This summary covers significant health news including FDA advisers rejecting Otsuka's PTSD treatment, Getinge exceeding ...

In a bold bid to electrify Wall Street and revolutionize how heart disease is diagnosed, Heartflow, a medical technology ...

Heartflow has filed for an initial public offering. The company recorded sales of $125.8 million and a net loss of $96.4 million last year, according to a filing with the Securities and Exchange ...

Heartflow, an artificial intelligence-based medical device software developer, filed for an initial public offering in the United States on Thursday. The U.S. IPO market is witnessing a renewed vigor ...

(Reuters) -MIAX-parent Miami International Holdings on Friday reported a wider quarterly loss in its filing for a U.S.

Rock Health, a Silicon Valley venture-capital fund and research firm, for the first time released a list of digital-health startups that are likely candidates to go public in the next 12 months ...

Heartflow Holding Inc. is aiming to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a merger with Longview Acquisition Corp.

Heartflow just raised $35.8 million. Its diagnostic software reconfigures medical imaging data, particularly from CT scans, to build 3D models of patients' coronary arteries for physicians to use.

Heartflow Holding Inc. is aiming to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a merger with Longview Acquisition Corp.

Heartflow Holding Inc (NYSE: HFLO) aims to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a SPAC merger with Longview ...